40B Stock Overview
An investment holding company, engages in the property investment and management business in the People’s Republic of China. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
HealthBank Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.10 |
52 Week High | S$0.10 |
52 Week Low | S$0.084 |
Beta | -0.48 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | 15.56% |
5 Year Change | 160.00% |
Change since IPO | -68.00% |
Recent News & Updates
Recent updates
Shareholder Returns
40B | SG Professional Services | SG Market | |
---|---|---|---|
7D | 0% | 1.5% | 0.007% |
1Y | n/a | 6.4% | 14.5% |
Return vs Industry: Insufficient data to determine how 40B performed against the SG Professional Services industry.
Return vs Market: Insufficient data to determine how 40B performed against the SG Market.
Price Volatility
40B volatility | |
---|---|
40B Average Weekly Movement | n/a |
Professional Services Industry Average Movement | 5.8% |
Market Average Movement | 4.4% |
10% most volatile stocks in SG Market | 14.8% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 40B's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine 40B's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 5 | George Peng | n/a |
HealthBank Holdings Limited, an investment holding company, engages in the property investment and management business in the People’s Republic of China. It offers landscaping, property, and facilities management services. The company was formerly known as SMJ International Holdings Ltd.
HealthBank Holdings Limited Fundamentals Summary
40B fundamental statistics | |
---|---|
Market cap | S$9.81m |
Earnings (TTM) | -S$6.53m |
Revenue (TTM) | S$9.11k |
1,077x
P/S Ratio-1.5x
P/E RatioIs 40B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
40B income statement (TTM) | |
---|---|
Revenue | CN¥49.00k |
Cost of Revenue | CN¥1.09m |
Gross Profit | -CN¥1.04m |
Other Expenses | CN¥34.11m |
Earnings | -CN¥35.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.37 |
Gross Margin | -2,118.37% |
Net Profit Margin | -71,726.53% |
Debt/Equity Ratio | 0% |
How did 40B perform over the long term?
See historical performance and comparison